- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01685866
3V- Improve Venous Access in Pediatric Anesthesia (3V)
August 5, 2014 updated by: Fondation Ophtalmologique Adolphe de Rothschild
Difficult Venous Access in Pediatric Anesthesia: Evaluation of a New Medical Device in Multicenter Trial.
Our hypothesis is that a new medical device called Vein-Viewer Vision helps to see peripheral veins in children having forecasted difficult venous access and could facilitate the venous access.The main goal is to reduce the time necessary to get a venous access during the inhalation anesthesia induction.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Randomized study comparing the delay of peripheral access with or without using the device.
Monosite study, including children undergoing surgery.
Study Type
Interventional
Enrollment (Actual)
311
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ile de France
-
Paris, Ile de France, France, 75019
- Robert Debré Hospital, APHP
-
-
Ile-de-France
-
Paris, Ile-de-France, France, 75019
- Fondation Ophtalmologique Adolphe de Rothschild
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 7 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- children aged less than 7
- DIVA score ≥ 4
- patient needing venous peripheral access for general anesthesia
Exclusion Criteria:
- no social security
- opposition of the parent(s) to the participation of their child in the trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: Vein-Viewer Vision
A medical device called Vein-Viewer Vision
|
A medical device called Vein-Viewer Vision
|
|
NO_INTERVENTION: no medical device
in the second arm, we use no medical device
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
reduce the time necessary to find the venous access during inhalation anesthesia induction
Time Frame: 1 day of anesthesia
|
1 day of anesthesia
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2012
Primary Completion (ACTUAL)
March 1, 2014
Study Completion (ACTUAL)
March 1, 2014
Study Registration Dates
First Submitted
September 12, 2012
First Submitted That Met QC Criteria
September 13, 2012
First Posted (ESTIMATE)
September 14, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
August 6, 2014
Last Update Submitted That Met QC Criteria
August 5, 2014
Last Verified
August 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SC/DM_JDS_2012-1_V1.0-20120605
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.